While Kaken News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from While Kaken. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In While Kaken Today - Breaking & Trending Today

Numab Therapeutics AG: Numab Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of NM26 Program

Published: May 15, 2023

NM26-2198 is a first-in-class bi-specific antibody designed to simultaneously block multiple targets for the treatment of moderate to severe atopic dermatitis (AD) Combined single ascending dose

Source: finanznachrichten.de

Related Topics:

United StatesDavid UrechSara MichelmorePeter LichtlenEuropean UnionChief Executive OfficerChief Medical OfficerKaken PharmaceuticalWhile KakenExecutive OfficerDougall AdvisorsGefallene Big Techs